Complete Filing Data
VYNE Therapeutics Inc. reported Stockholders Equity of $27.77 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean VYNE Therapeutics Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$26.5M | -$39.8M | -$28.5M | -$23.2M | -$73.3M | -$255.6M | -$95.2M | -$74.2M | -$29.1M | -$14.1M | -$4.6M |
| Revenue * | $570.0K | $501.0K | $424.0K | $477.0K | $931.0K | $21.0M | $443.0K | $3.6M | $4.6M | $674.0K | |
| Operating Income Loss | -$29.7M | -$43.6M | -$29.3M | -$34.3M | -$38.9M | -$252.5M | -$95.9M | -$74.9M | -$29.6M | -$14.3M | -$4.6M |
| Research And Development Expense | $19.2M | $30.9M | $16.3M | $18.4M | $19.5M | $43.5M | $51.2M | $64.5M | $29.0M | $11.3M | $2.9M |
| Other Nonoperating Income Expense | $3.0M | $3.8M | $1.4M | $363.0K | -$135.0K | $1.1M | -$1.4M | -$941.0K | $517.0K | $264.0K | |
| Comprehensive Income Net Of Tax | -$26.5M | -$39.8M | -$28.4M | -$23.2M | -$73.3M | -$255.6M | -$95.1M | -$74.1M | -$29.1M | -$14.1M | -$4.6M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$26.7M | -$39.8M | -$27.9M | -$33.9M | -$44.7M | -$255.8M | -$95.4M | -$74.0M | |||
| Income Tax Expense Benefit | $4.0K | $4.0K | $0.00 | $13.0K | -$448.0K | -$258.0K | -$176.0K | $212.0K | |||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $1.0K | $47.0K | $59.0K | -$25.0K | -$26.0K | $0.00 | ||||
| Operating Expenses | $76.2M | $65.2M | $34.2M | $15.0M | $4.6M | ||||||
| General And Administrative Expense | $11.1M | $13.2M | $13.4M | $16.4M | $22.5M | $12.2M | $5.2M | $3.8M | $1.7M | ||
| Selling General And Administrative Expense | $16.4M | $20.3M | $89.5M | $45.1M | $14.0M | ||||||
| Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity | $253.0K | -$27.0K | -$580.0K | $10.7M | -$29.1M | ||||||
| Income Loss From Continuing Operations Per Diluted Share | -$0.63 | -$0.93 | -$2.72 | -$10.65 | -$15.46 | ||||||
| Income Loss From Continuing Operations Per Basic Share | -$0.63 | -$0.93 | -$2.72 | -$10.65 | -$15.46 | ||||||
| Income Loss From Continuing Operations | -$26.7M | -$39.8M | -$27.9M | -$33.9M | -$44.2M | ||||||
| Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share | $0.01 | $0.00 | -$0.06 | $3.37 | -$10.18 | ||||||
| Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share | $0.01 | $0.00 | -$0.06 | $3.37 | -$10.18 | ||||||
| Cost Of Goods And Services Sold | $3.3M | $1.4M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$5.8M | -$8.6M | -$12.2M | -$9.4M | -$6.2M | -$6.6M | -$10.1M | -$5.6M | -$9.5M | -$8.5M | $4.7M | -$21.3M | -$19.9M | -$20.6M | -$24.7M | -$167.4M | -$40.2M | -$21.5M | -$23.2M | -$19.0M | -$15.2M | -$17.6M | -$12.8M | -$8.3M | -$12.7M | -$9.3M | -$8.2M | -$6.2M | -$5.5M | -$4.8M | -$3.4M | -$3.6M | -$2.3M | |
| Revenue * | $69.0K | $202.0K | $121.0K | $198.0K | $98.0K | $114.0K | $135.0K | $99.0K | $167.0K | $126.0K | $178.0K | $133.0K | $295.0K | $230.0K | $3.3M | $11.7M | $1.8M | $0.00 | $0.00 | $308.0K | $10.1M | $497.0K | $2.8M | $909.0K | $449.0K | $449.0K | ||||||||
| Operating Income Loss | -$7.5M | -$9.2M | -$13.1M | -$10.4M | -$7.4M | -$6.2M | -$10.3M | -$5.9M | -$9.3M | -$8.3M | -$8.7M | -$10.8M | -$9.5M | -$9.8M | -$22.0M | -$23.5M | -$167.2M | -$39.9M | -$37.4M | -$23.2M | -$19.4M | -$15.9M | -$13.7M | -$9.2M | -$13.2M | -$8.3M | -$6.2M | -$5.6M | ||||||
| Research And Development Expense | $4.9M | $6.1M | $10.2M | $7.3M | $3.7M | $3.3M | $7.2M | $2.7M | $5.5M | $4.1M | $4.5M | $5.9M | $5.0M | $4.3M | $6.6M | $13.1M | $16.0M | $12.5M | $12.6M | $10.8M | $10.7M | $16.2M | $11.0M | $8.0M | $5.5M | $5.0M | ||||||||
| Other Nonoperating Income Expense | $1.8M | $594.0K | $934.0K | $1.0M | $1.1M | $163.0K | $280.0K | $263.0K | $78.0K | $52.0K | -$3.0K | -$35.0K | -$69.0K | -$57.0K | -$130.0K | $548.0K | $723.0K | $571.0K | $739.0K | $796.0K | $855.0K | $826.0K | $563.0K | $163.0K | ||||||||||
| Comprehensive Income Net Of Tax | -$5.8M | -$8.6M | -$12.1M | -$9.4M | -$6.3M | -$6.6M | -$10.1M | -$5.6M | -$21.3M | -$19.9M | -$20.6M | -$24.7M | -$167.4M | -$40.3M | -$23.2M | -$19.0M | -$15.2M | -$12.8M | -$8.3M | -$12.8M | -$8.2M | -$6.1M | -$5.5M | |||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$5.7M | -$8.6M | -$12.2M | -$9.4M | -$6.2M | -$6.1M | -$10.0M | -$5.6M | -$9.3M | -$8.2M | -$8.7M | -$14.3M | -$10.7M | -$10.9M | -$24.7M | -$167.7M | -$40.2M | -$23.2M | -$19.0M | -$15.4M | ||||||||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.0K | -$259.0K | $0.00 | $0.00 | $0.00 | -$176.0K | ||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $0.00 | $0.00 | $2.0K | $43.0K | -$44.0K | $1.0K | $4.0K | $36.0K | $48.0K | $53.0K | -$151.0K | -$19.0K | $8.0K | -$4.0K | |||||||||||||||||||
| Operating Expenses | $21.9M | $17.4M | $17.2M | $19.7M | $18.4M | $13.7M | $19.3M | $13.7M | $12.3M | $9.2M | $6.7M | $6.0M | $5.4M | $3.7M | $3.6M | $2.3M | ||||||||||||||||||
| General And Administrative Expense | $2.7M | $3.3M | $3.0M | $3.3M | $3.8M | $3.0M | $3.2M | $3.2M | $4.8M | $3.8M | $3.7M | $3.0M | $3.1M | $2.7M | $1.2M | $1.2M | $1.0M | |||||||||||||||||
| Selling General And Administrative Expense | $3.0M | $3.2M | $3.2M | $4.0M | $4.3M | $4.4M | $5.0M | $4.8M | $5.7M | $19.8M | $26.5M | $25.4M | $10.7M | $6.8M | $5.3M | |||||||||||||||||||
| Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity | -$8.0K | -$8.0K | $0.00 | -$11.0K | -$8.0K | -$513.0K | -$20.0K | -$10.0K | -$204.0K | -$241.0K | $13.4M | -$7.0M | -$9.2M | -$9.7M | ||||||||||||||||||||
| Income Loss From Continuing Operations Per Diluted Share | -$0.13 | -$0.20 | -$0.29 | -$0.22 | -$0.15 | -$1.85 | -$3.08 | -$1.74 | -$2.88 | -$2.56 | -$2.83 | -$0.27 | -$0.21 | -$0.22 | ||||||||||||||||||||
| Income Loss From Continuing Operations Per Basic Share | -$0.13 | -$0.20 | -$0.29 | -$0.22 | -$0.15 | -$1.85 | -$3.08 | -$1.74 | -$2.88 | -$2.56 | -$2.83 | -$0.27 | -$0.21 | -$0.22 | ||||||||||||||||||||
| Income Loss From Continuing Operations | -$5.7M | -$8.6M | -$12.2M | -$9.4M | -$6.2M | -$6.1M | -$10.0M | -$5.6M | -$9.3M | -$8.2M | -$8.7M | -$14.3M | -$10.7M | -$10.9M | ||||||||||||||||||||
| Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.16 | -$0.01 | $0.00 | -$0.06 | -$0.07 | $4.34 | -$0.14 | -$0.18 | -$0.20 | ||||||||||||||||||||
| Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.16 | -$0.01 | $0.00 | -$0.06 | -$0.07 | $4.34 | -$0.14 | -$0.18 | -$0.20 | ||||||||||||||||||||
| Cost Of Goods And Services Sold | $1.0M | $795.0K | $601.0K | $371.0K | $216.0K | $271.0K | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $27.8M | $52.1M | $88.7M | $31.2M | $48.6M | $37.5M | $17.6M | $92.2M | $68.6M | -$29.4M | -$16.0M | -$11.4M |
| Cash And Cash Equivalents At Carrying Value | $24.0M | $19.9M | $30.6M | $30.9M | $42.3M | $57.6M | $43.8M | $27.9M | $4.0M | $43.8M | $273.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $24.0M | $19.9M | $30.7M | $31.0M | $42.9M | $58.4M | $44.6M | $28.1M | $16.2M | |||
| Retained Earnings Accumulated Deficit | -$757.7M | -$731.2M | -$691.3M | -$662.7M | -$639.5M | -$566.2M | -$310.6M | -$110.6M | -$59.2M | -$30.1M | ||
| Prepaid Expense And Other Assets Current | $1.0M | $2.9M | $2.7M | $2.3M | $4.6M | $4.6M | $1.6M | $3.3M | $3.6M | $632.0K | ||
| Liabilities And Stockholders Equity | $30.2M | $66.9M | $97.7M | $40.8M | $67.0M | $93.7M | $81.2M | $139.9M | $66.9M | $42.1M | ||
| Liabilities | $2.4M | $14.8M | $9.0M | $9.3M | $18.4M | $56.2M | $63.6M | $9.6M | $14.6M | $12.5M | ||
| Common Stock Value | $3.0K | $1.0K | $1.0K | $0.00 | $5.0K | $4.0K | $1.0K | $3.0K | $1.0K | $1.0K | ||
| Assets Current | $30.0M | $64.4M | $96.0M | $38.3M | $63.2M | $87.3M | $76.4M | $139.5M | $63.9M | $31.5M | ||
| Assets | $30.2M | $66.9M | $97.7M | $40.8M | $67.0M | $93.7M | $81.2M | $139.9M | $66.9M | $42.1M | ||
| Accrued Liabilities Current | $941.0K | $9.3M | $4.1M | $4.4M | $8.6M | $11.5M | $3.4M | $6.3M | $3.6M | $581.0K | ||
| Liabilities Current | $2.4M | $14.8M | $7.5M | $9.3M | $18.4M | $21.8M | $29.3M | $9.5M | $7.8M | $3.9M | ||
| Property Plant And Equipment Net | $90.0K | $113.0K | $0.00 | $0.00 | $354.0K | $555.0K | $2.9M | $146.0K | $28.0K | $27.0K | ||
| Prepaid Expense And Other Assets Noncurrent | $60.0K | $2.3M | $282.0K | $0.00 | $66.0K | |||||||
| Employee Related Liabilities Current | $413.0K | $1.4M | $1.6M | $2.4M | $2.8M | $4.4M | $5.2M | |||||
| Accounts Payable Trade Current | $1.0M | $2.7M | $1.7M | $2.4M | $6.5M | $4.8M | $19.4M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $2.0K | $20.0K | $26.0K | $0.00 | $0.00 | $0.00 | $5.0K | -$96.0K | -$51.0K | -$26.0K | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Operating Lease Right Of Use Asset | $0.00 | $93.0K | $207.0K | $0.00 | $0.00 | $1.6M | $1.7M | |||||
| Operating Lease Liability Current | $0.00 | $99.0K | $115.0K | $0.00 | $349.0K | $757.0K | $1.1M | |||||
| Restricted Cash And Cash Equivalents At Carrying Value | $0.00 | $54.0K | $67.0K | $605.0K | $855.0K | $825.0K | ||||||
| Restricted Cash And Cash Equivalents | $0.00 | $54.0K | $67.0K | $605.0K | $855.0K | $825.0K | $250.0K | |||||
| Accounts Receivable Net Current | $7.6M | $15.8M | $135.0K | $786.0K | $0.00 | |||||||
| Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | $0.00 | $0.00 | $211.0K | $0.00 | $0.00 | |||||||
| Unrealized Gain Loss On Investments | $0.00 | $1.0K | -$1.0K | $0.00 | $0.00 | $142.0K | $357.0K | -$201.0K | $25.0K | $26.0K | $0.00 | |
| Marketable Securities Current | $5.0M | $41.6M | $62.6M | $0.00 | $0.00 | $1.0M | $16.2M | |||||
| Other Liabilities | $0.00 | $1.3M | $0.00 | $0.00 | $457.0K | $456.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $38.9M | $44.1M | $63.5M | $74.9M | $83.4M | $11.5M | $17.3M | $26.4M | $40.1M | $48.4M | $55.7M | $58.9M | $74.9M | $92.9M | $49.5M | $71.5M | $69.5M | $53.5M | $60.4M | $78.0M | $146.9M | $158.2M | $165.7M | |||||||||
| Cash And Cash Equivalents At Carrying Value | $22.0M | $28.2M | $16.3M | $29.6M | $19.1M | $15.4M | $20.6M | $30.2M | $35.5M | $42.8M | $50.5M | $52.3M | $103.4M | $118.5M | $73.0M | $96.5M | $57.6M | $40.5M | $39.1M | $19.0M | $70.2M | $73.6M | $78.5M | $10.2M | $15.0M | $13.4M | $6.0M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $22.0M | $28.2M | $16.3M | $29.7M | $19.1M | $15.5M | $20.7M | $30.3M | $35.6M | $42.8M | $51.1M | $52.9M | $104.0M | $119.4M | $73.8M | $97.4M | $58.5M | $40.8M | $39.3M | $19.2M | ||||||||||||
| Retained Earnings Accumulated Deficit | -$745.5M | -$739.8M | -$719.1M | -$707.0M | -$697.6M | -$685.1M | -$678.6M | -$668.5M | -$652.8M | -$643.3M | -$634.9M | -$628.0M | -$606.7M | -$586.7M | -$543.0M | -$518.3M | -$350.9M | -$162.8M | -$146.0M | -$129.5M | -$93.0M | -$80.2M | -$71.8M | |||||||||
| Prepaid Expense And Other Assets Current | $4.7M | $4.6M | $3.3M | $5.6M | $4.2M | $1.8M | $2.0M | $2.6M | $3.0M | $3.8M | $3.9M | $5.1M | $5.3M | $3.9M | $3.5M | $2.7M | $4.2M | $2.1M | $3.7M | $3.7M | $1.8M | $2.3M | $3.6M | |||||||||
| Liabilities And Stockholders Equity | $44.7M | $56.4M | $76.2M | $86.6M | $91.7M | $19.3M | $25.0M | $35.3M | $46.9M | $55.2M | $64.3M | $81.3M | $134.0M | $149.2M | $107.7M | $130.8M | $160.5M | $96.6M | $114.4M | $126.3M | $155.0M | $166.9M | $180.5M | |||||||||
| Liabilities | $5.8M | $12.3M | $12.7M | $11.8M | $8.3M | $7.8M | $7.7M | $8.8M | $6.8M | $6.8M | $8.6M | $22.4M | $59.1M | $56.3M | $58.2M | $59.3M | $91.0M | $9.6M | $12.2M | $10.6M | $8.1M | $8.7M | $14.8M | |||||||||
| Common Stock Value | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $0.00 | $0.00 | $0.00 | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $17.0K | $17.0K | $6.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |||||||||
| Assets Current | $44.3M | $54.9M | $73.5M | $83.8M | $90.2M | $17.5M | $23.0M | $33.0M | $44.0M | $51.9M | $60.7M | $76.1M | $128.4M | $143.1M | $98.2M | $119.3M | $98.4M | $93.4M | $113.1M | $125.2M | $154.5M | $156.2M | $159.7M | |||||||||
| Assets | $44.7M | $56.4M | $76.2M | $86.6M | $91.7M | $19.3M | $25.0M | $35.3M | $46.9M | $55.2M | $64.3M | $81.3M | $134.0M | $149.2M | $107.7M | $130.8M | $160.5M | $96.6M | $114.4M | $126.3M | $155.0M | $166.9M | $180.5M | |||||||||
| Accrued Liabilities Current | $3.6M | $6.9M | $6.2M | $5.1M | $3.6M | $4.5M | $4.4M | $4.2M | $2.2M | $3.5M | $3.3M | $9.6M | $10.1M | $13.5M | $12.1M | $8.8M | $12.5M | $5.7M | $6.5M | $6.2M | $5.4M | $3.6M | $3.2M | |||||||||
| Liabilities Current | $5.8M | $12.3M | $12.7M | $11.8M | $6.9M | $6.4M | $6.4M | $7.5M | $21.0M | $57.6M | $21.5M | $23.2M | $24.2M | $56.6M | $9.5M | $11.9M | $10.6M | $8.1M | $8.6M | $8.5M | ||||||||||||
| Property Plant And Equipment Net | $102.0K | $107.0K | $127.0K | $298.0K | $310.0K | $472.0K | $501.0K | $529.0K | $2.7M | $2.8M | $2.8M | $113.0K | $128.0K | $143.0K | $136.0K | $22.0K | $25.0K | |||||||||||||||
| Prepaid Expense And Other Assets Noncurrent | $241.0K | $1.3M | $2.5M | $2.7M | $1.3M | $1.5M | $1.8M | $2.0M | $2.2M | $2.5M | $2.7M | $3.0M | $3.4M | $3.5M | $3.7M | $3.8M | $4.1M | $4.3M | $4.6M | $6.2M | $3.2M | $166.0K | $200.0K | $144.0K | $223.0K | |||||||
| Employee Related Liabilities Current | $819.0K | $523.0K | $1.1M | $736.0K | $376.0K | $1.3M | $836.0K | $910.0K | $1.9M | $1.6M | $1.3M | $3.4M | $3.5M | $3.8M | $5.3M | $4.1M | $7.8M | |||||||||||||||
| Accounts Payable Trade Current | $1.4M | $3.5M | $4.0M | $4.5M | $2.8M | $716.0K | $1.2M | $2.2M | $2.5M | $1.4M | $3.6M | $7.6M | $10.1M | $3.5M | $4.6M | $10.0M | $14.1M | |||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$2.0K | $0.00 | $34.0K | -$58.0K | -$70.0K | $0.00 | $0.00 | -$40.0K | $35.0K | $5.0K | -$10.0K | -$101.0K | -$150.0K | -$202.0K | ||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Operating Lease Right Of Use Asset | $32.0K | $62.0K | $122.0K | $151.0K | $180.0K | $1.0M | $1.2M | $1.4M | $2.2M | $2.6M | $1.7M | $830.0K | $985.0K | $670.0K | ||||||||||||||||||
| Operating Lease Liability Current | $25.0K | $63.0K | $123.0K | $120.0K | $117.0K | $0.00 | $31.0K | $117.0K | $277.0K | $434.0K | $647.0K | $1.1M | $1.2M | $1.0M | ||||||||||||||||||
| Restricted Cash And Cash Equivalents At Carrying Value | $47.0K | $46.0K | $54.0K | $54.0K | $67.0K | $67.0K | $67.0K | $0.00 | $605.0K | $605.0K | $605.0K | $855.0K | $855.0K | $855.0K | $855.0K | |||||||||||||||||
| Restricted Cash And Cash Equivalents | $0.00 | $0.00 | $47.0K | $46.0K | $54.0K | $54.0K | $67.0K | $67.0K | $67.0K | $0.00 | $605.0K | $605.0K | $605.0K | $855.0K | $855.0K | $855.0K | $855.0K | $250.0K | ||||||||||||||
| Accounts Receivable Net Current | $250.0K | $234.0K | $105.0K | $173.0K | $471.0K | $304.0K | $535.0K | $10.1M | $10.9M | $10.8M | $11.2M | $6.4M | $8.3M | $93.0K | $234.0K | |||||||||||||||||
| Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||
| Unrealized Gain Loss On Investments | $0.00 | $1.0K | $0.00 | $0.00 | $153.0K | $264.0K | ||||||||||||||||||||||||||
| Marketable Securities Current | $17.6M | $22.1M | $53.9M | $48.5M | $66.9M | $0.00 | $0.00 | $1.0M | $3.0M | $2.6M | $23.8M | |||||||||||||||||||||
| Other Liabilities | $0.00 | $0.00 | $1.3M | $1.3M | $1.3M | $1.3M | $451.0K | $452.0K | $457.0K | $457.0K | $456.0K | $456.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $2.3M | $3.3M | $3.3M | $4.3M | $8.1M | $18.1M | $4.9M | $5.3M | $5.3M | $573.0K | $65.0K |
| Stock Issued During Period Value Share Based Compensation | -$128.0K | -$112.0K | -$18.0K | $9.0K | $410.0K | $554.0K | $617.0K | $47.0K | |||
| Net Cash Provided By Used In Operating Activities | -$33.1M | -$34.0M | -$25.3M | -$29.2M | -$56.4M | -$137.1M | -$73.4M | -$68.7M | -$28.2M | -$2.3M | -$4.2M |
| Net Cash Provided By Used In Investing Activities | $37.4M | $23.4M | -$57.4M | $15.7M | $1.0M | $89.1M | $41.9M | -$11.8M | -$15.1M | -$37.5M | $0.00 |
| Net Cash Provided By Used In Financing Activities | -$143.0K | -$141.0K | $82.4M | $1.7M | $39.8M | $61.8M | $48.0M | $92.4M | $49.5M | $0.00 | $47.7M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$12.3M | $6.0M | -$559.0K | -$8.7M | -$2.7M | -$13.0M | $18.1M | $238.0K | |||
| Proceeds From Issuance Of Common Stock | $1.5M | $76.0M | $61.6M | $13.7M | $91.5M | ||||||
| Depreciation Depletion And Amortization | $23.0K | $4.0K | $0.00 | $72.0K | $109.0K | $341.0K | $350.0K | $319.0K | |||
| Proceeds From Sale And Maturity Of Marketable Securities | $68.3M | $84.0M | $0.00 | $0.00 | $1.0M | $50.6M | $87.9M | $66.5M | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$4.2M | $899.0K | -$405.0K | -$11.2M | -$7.7M | $17.1M | -$373.0K | $308.0K | |||
| Increase Decrease In Other Noncurrent Assets | $0.00 | -$841.0K | $4.2M | $131.0K | $14.0K | -$66.0K | $66.0K | ||||
| Increase Decrease In Operating Lease Liability | -$99.0K | -$114.0K | $214.0K | -$349.0K | -$1.2M | -$614.0K | |||||
| Proceeds From Stock Options Exercised | $522.0K | $310.0K | $365.0K | $47.0K | $34.0K | $0.00 | $98.0K | ||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $113.0K | $1.1M | $567.0K | $27.0K | $31.0K | $0.00 | ||||
| Increase Decrease In Inventories | $0.00 | -$97.0K | -$113.0K | $6.0M | $1.4M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $763.0K | $985.0K | $856.0K | $893.0K | $2.4M | $1.8M | $950.0K | $822.0K | $316.0K | |||||||||||||
| Stock Issued During Period Value Share Based Compensation | -$22.0K | -$87.0K | -$1.0K | $8.0K | -$5.0K | -$46.0K | $23.0K | -$12.0K | -$3.0K | $25.0K | -$25.0K | -$10.0K | $15.0K | $388.0K | $82.0K | -$43.0K | $303.0K | $26.0K | $2.0K | $16.0K | ||
| Net Cash Provided By Used In Operating Activities | -$11.5M | -$8.0M | -$5.5M | -$9.0M | -$12.6M | -$52.2M | -$16.6M | -$11.2M | -$5.6M | |||||||||||||
| Net Cash Provided By Used In Investing Activities | $19.8M | -$3.6M | $5.0M | $15.8M | $0.00 | $66.0M | $7.7M | -$45.9M | $7.6M | |||||||||||||
| Net Cash Provided By Used In Financing Activities | -$87.0K | -$5.0K | -$217.0K | $1.5M | $73.5M | $140.0K | $16.0K | $125.4M | $0.00 | |||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$2.5M | -$611.0K | -$512.0K | -$9.6M | $205.0K | $856.0K | -$1.9M | |||||||||||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $156.0K | $1.6M | $73.1M | $0.00 | $2.6M | $125.4M | $0.00 | ||||||||||||||
| Depreciation Depletion And Amortization | $6.0K | $0.00 | $0.00 | $44.0K | $27.0K | $93.0K | $76.0K | |||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $33.6M | $11.6M | $0.00 | $0.00 | $27.4M | $15.9M | ||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $768.0K | $1.3M | $200.0K | -$5.8M | $9.3M | $300.0K | ||||||||||||||||
| Increase Decrease In Other Noncurrent Assets | $0.00 | -$404.0K | $3.0M | $4.0K | $85.0K | -$66.0K | ||||||||||||||||
| Increase Decrease In Operating Lease Liability | -$37.0K | -$34.0K | $0.00 | -$232.0K | $0.00 | -$163.0K | ||||||||||||||||
| Proceeds From Stock Options Exercised | $376.0K | $140.0K | $16.0K | |||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $42.0K | $138.0K | |||||||||||||||||||
| Increase Decrease In Inventories | $0.00 | -$97.0K | $688.0K | $1.8M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.62 | -$0.93 | -$2.78 | -$7.28 | -$25.64 | $7.88 | $11.22 | $11.47 | -$5.69 | -$2.82 | -$0.97 |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 75.0M | 75.0M | 75.0M | 300.0M | 55.0M | 36.5M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 33.3M | 14.8M | 14.1M | 3.2M | 3.0M | 43.2M | 9.1M | 23.2M | 5.3M | 5.3M | |
| Common Stock Shares Issued | 33.3M | 14.8M | 14.1M | 3.2M | 3.0M | 43.2M | 9.1M | 23.2M | 5.3M | 5.3M | |
| Weighted Average Number Of Shares Outstanding Basic | 42.8M | 42.6M | 10.3M | 3.2M | 2.9M | 32.4M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 42.8M | 42.6M | 10.3M | 3.2M | 2.9M | 32.4M | |||||
| Earnings Per Share Basic | $-0.62 | $-0.93 | $-2.78 | $-7.28 | $-25.64 | $7.88 | |||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 0.00 | 0.00 | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 32.4M | 8.5M | 6.5M | 5.1M | 5.0M | 4.7M | |||||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 3.0K | 0.00 | 0.00 | 26.0M | 14.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.13 | -$0.20 | -$0.29 | -$0.22 | -$0.15 | -$2.01 | -$3.09 | -$1.74 | -$2.94 | -$2.63 | $1.51 | -$0.41 | -$0.39 | -$0.42 | $0.55 | -$0.59 | -$4.83 | $3.79 | $4.17 | $2.79 | $2.36 | $1.89 | -$0.76 | -$0.56 | -$0.36 | -$0.72 | -$1.80 | -$1.59 | -$1.21 | -$1.08 | -$0.96 | -$0.68 | -$0.72 | -$0.43 | |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 75.0M | 75.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | ||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Common Stock Shares Outstanding | 19.8M | 16.0M | 14.8M | 14.5M | 14.3M | 3.3M | 3.3M | 3.3M | 58.0M | 58.0M | 57.9M | 53.5M | 51.5M | 51.4M | 167.9M | 167.7M | 61.5M | 24.0M | 23.9M | 23.7M | 23.2M | 23.0M | 23.0M | ||||||||||||
| Common Stock Shares Issued | 19.8M | 16.0M | 14.8M | 14.5M | 14.3M | 3.3M | 3.3M | 3.3M | 58.0M | 58.0M | 57.9M | 53.5M | 51.5M | 51.4M | 167.9M | 167.7M | 61.5M | 24.0M | 23.9M | 23.7M | 23.2M | 23.0M | 23.0M | ||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 42.8M | 42.7M | 42.6M | 42.6M | 42.6M | 3.3M | 3.3M | 3.3M | 3.2M | 3.2M | 3.1M | 52.0M | 51.4M | 48.9M | 41.9M | 34.7M | |||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 42.8M | 42.7M | 42.6M | 42.6M | 42.6M | 3.3M | 3.3M | 3.3M | 3.2M | 3.2M | 3.1M | 52.0M | 51.4M | 48.9M | 41.9M | 34.7M | |||||||||||||||||||
| Earnings Per Share Basic | $-0.13 | $-0.20 | $-0.29 | $-0.22 | $-0.15 | $-2.01 | $-3.09 | $-1.74 | $-2.94 | $-2.63 | $1.51 | $-0.41 | $-0.39 | $-0.42 | $-0.59 | $-4.83 | |||||||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||||
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | |||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 48.9M | 167.7M | 138.7M | 10.6M | 100.8M | 98.0M | 32.2M | 23.0M | 22.9M | 17.6M | 5.1M | 5.1M | 5.1M | ||||||||||||||||||||||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | $30.3M | $44.1M | $29.7M | $34.8M | $39.8M | $272.1M | $96.3M | $78.5M | |
| Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options | $2.3M | $3.3M | $3.3M | $4.3M | $8.1M | $18.1M | $4.9M | $5.3M | |
| Additional Paid In Capital | $785.4M | $783.2M | $780.0M | $693.9M | $688.2M | $603.7M | $328.2M | $699.0K | |
| Stock Issued1 | $16.0K | $30.0K | $48.0K | $37.0K | $169.0K | $387.0K | $284.0K | $0.00 | |
| Supplemental Unemployment Benefits Severance Benefits | $0.00 | $206.0K | $206.0K | $312.0K | $424.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q1 2018 | Q4 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | $7.6M | $9.4M | $13.2M | $10.6M | $7.5M | $6.3M | $10.5M | $6.0M | $9.5M | $8.4M | $8.9M | $10.9M | $9.8M | $10.0M | $26.4M | $178.6M | $41.4M | $23.2M | $19.4M | $16.2M | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options | $529.0K | $763.0K | $734.0K | $885.0K | $985.0K | $863.0K | $876.0K | $856.0K | $1.2M | $1.2M | $893.0K | $2.4M | $1.9M | $2.4M | $2.6M | $10.8M | $1.8M | $1.3M | $1.4M | $950.0K | ||
| Additional Paid In Capital | $784.4M | $783.9M | $782.7M | $781.9M | $781.0M | $696.7M | $695.8M | $694.9M | $692.9M | $691.7M | $690.6M | $686.8M | $681.6M | $679.6M | $592.5M | $589.8M | $420.4M | $237.7M | $2.2M | |||
| Stock Issued1 | $0.00 | $163.0K | ||||||||||||||||||||
| Supplemental Unemployment Benefits Severance Benefits | $0.00 | $0.00 | $206.0K | $208.0K | $256.0K | $216.0K | $206.0K | $206.0K | $206.0K | $409.0K | $403.0K | $411.0K |
Most recent annual filing with the SEC: February 27, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.